Preparation method of favipiravir
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- BEIJING SIHUAN PHARMA
- Publication Date
- 2021-08-13
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of drug synthesis, and in particular relates to a preparation method of Favipiravir. Background technique
[0002] Favipiravir (trade name AVIGAN) is an RNA-dependent RNA polymerase (RdRp) inhibitor broad-spectrum antiviral drug developed by Japan Fukuyama Chemical Co., Ltd. Bioterrorism attacks have important practical significance.
[0003]
[0004] CN1418220A discloses the preparation method of Favipiravir, comprising the following steps:
[0005]
[0006] This method has the following problems in the process of preparing 6-fluoro-3-hydroxyl-2-cyanopyrazine (compound II): one, heterogeneous reaction, stirring difficulty, increase processing difficulty; pH, extraction, washing, and drying and decompression to remove the solvent are cumbersome and costly. Third, column chromatography is used for purification, which is not suitable for industrial production. Fourth, the yield of this step is only 45.6%, and th...